Enfusion Inc (ENFN)
10.63
+0.16
(+1.53%)
USD |
NYSE |
Dec 20, 16:00
10.64
0.00 (0.00%)
Pre-Market: 20:00
Enfusion Research and Development Expense (Quarterly): 6.842M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
F5 Inc | 123.95M |
DigitalOcean Holdings Inc | 37.38M |
Klaviyo Inc | 55.77M |
Castellum Inc | -- |
BM Technologies Inc | -- |